dilazep has been researched along with losartan potassium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hosoya, T; Kuriyama, S; Tomonari, H | 1 |
1 other study(ies) available for dilazep and losartan potassium
Article | Year |
---|---|
Antiplatelet therapy decreases the incidence of erythropoietin-induced hypertension in predialysis patients.
Topics: Adult; Aged; Anemia; Dilazep; Dipyridamole; Erythropoietin; Female; Hematocrit; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Platelet Aggregation Inhibitors; Recombinant Proteins; Renal Dialysis; Risk Factors | 1999 |